Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2011, Article ID 345012, 4 pages
http://dx.doi.org/10.1155/2011/345012
Clinical Study

Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients

1Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City, UT 84113-1103, USA
2Pharmacy Department, Primary Children's Medical Center, Salt Lake City, UT 84113-1100, USA
3Department of Pediatrics, Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City, UT 84113-1100, USA
4Pharmacy Department, MaKay-Dee Hospital Center, Intermountain Healthcare, Ogden, UT 84403, USA
5Department of Pediatric Pulmonology, Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City, UT 84158, USA

Received 9 August 2011; Revised 19 September 2011; Accepted 20 September 2011

Academic Editor: P. Gionchetti

Copyright © 2011 John F. Pohl et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • John F. Pohl, “Clostridium difficile infection and proton pump inhibitors,” Current Opinion In Pediatrics, vol. 24, no. 5, pp. 627–631, 2012. View at Publisher · View at Google Scholar
  • Daniel Gelfond, and Drucy Borowitz, “Gastrointestinal Complications of Cystic Fibrosis,” Clinical Gastroenterology and Hepatology, vol. 11, no. 4, pp. 333–342, 2013. View at Publisher · View at Google Scholar
  • Maria Pleguezuelo, Jose Manuel Benitez, Juan Jurado, Jose Luis Montero, and Manuel De la Mata, “Diagnosis and management of bacterial infections in decompensated cirrhosis.,” World journal of hepatology, vol. 5, no. 1, pp. 16–25, 2013. View at Publisher · View at Google Scholar
  • Maria Pleguezuelo, Jose Manuel Benitez, Juan Jurado, Jose Luis Montero, and Manuel De La Mata, “Diagnosis and management of bacterial infections in decompensated cirrhosis,” World Journal of Hepatology, vol. 5, no. 1, pp. 16–25, 2013. View at Publisher · View at Google Scholar
  • Abhishek Deshpande, Muhammad A. Altaf, Anil Minocha, and Chaitanya Pant, “Clostridium difficile infection in children: a comprehensive review,” Current Medical Research And Opinion, vol. 29, no. 8, pp. 967–984, 2013. View at Publisher · View at Google Scholar
  • Prasad Nagakumar, “Pseudomembranous colitis in cystic fibrosis,” Paediatric Respiratory Reviews, vol. 14, no. 1, pp. 26–27, 2013. View at Publisher · View at Google Scholar
  • Katelyn E. Brown, Chad A. Knoderer, Kristen R. Nichols, and Ashley S. Crumby, “Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric Patients,” Clinical Pediatrics, vol. 54, no. 11, pp. 1102–1106, 2015. View at Publisher · View at Google Scholar
  • Lees, Miyajima, Pirmohamed, and Carrol, “The role of Clostridium difficile in the paediatric and neonatal gut — a narrative review,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 35, no. 7, pp. 1047–1057, 2016. View at Publisher · View at Google Scholar
  • L. Kessler, and M. Abély, “Atteinte pancréatique exocrine et endocrine dans la mucoviscidose,” Archives de Pédiatrie, vol. 23, no. 12, pp. 12S21–12S32, 2016. View at Publisher · View at Google Scholar
  • Patrizia Spigaglia, Fabrizio Barbanti, Elio Castagnola, Maria Cristina Diana, Luisa Pescetto, and Roberto Bandettini, “Clostridium difficile causing pediatric infections: New findings from a hospital-based study in Italy,” Anaerobe, 2017. View at Publisher · View at Google Scholar
  • Amandeep Singh, Gail A. Cresci, and Donald F. Kirby, “Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome,” Nutrition in Clinical Practice, 2018. View at Publisher · View at Google Scholar
  • Bradley E. McCrory, Heidi N. Harper, and Gary L. McPhail, “Use and Incidence of Adverse Effects of Proton Pump Inhibitors in Patients with Cystic Fibrosis,” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2018. View at Publisher · View at Google Scholar
  • Archana Chatterjee, and Maya Gogoi, “Update in Pediatric Infectious Disease,” Update in Pediatrics, pp. 349–368, 2018. View at Publisher · View at Google Scholar